Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dopamine Receptor Availability and Insulin Resistance

NCT00802204 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00802204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00802204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dopamine Receptor Availability and Insulin Resistance
Lead sponsor
Vanderbilt University
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2008
Completion date
December 31, 2012
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity